RTI Surgical

Regeneration Technologies, Inc., operating as RTI Surgical, is a company based in Alachua, Florida. The company is a leader in tissue-based innovations for medical applications, employing 2 people and generating $280 million in revenue. RTI Surgical processes human musculoskeletal and other tissues, including bone, cartilage, tendon, ligament, pericardial, and cardiovascular tissue, to create allograft implants. These allografts are used by surgeons to repair a variety of bone and tissue defects, such as spinal vertebrae repair, musculoskeletal reconstruction, fracture repair, periodontal repair, urinary incontinence, and heart valve disorders. The company's unique BioCleanse™ tissue sterilization process is a patented technology validated to eliminate bacteria, fungi, spores, and viruses from the tissue. This process also removes blood, fats, lipids, and cellular debris, resulting in whiter tissue compared to aseptically processed tissue. RTI Surgical stands out as the only company in the industry to utilize this sterilization process, which has undergone review by the FDA. For more information about RTI Surgical and its products, you can visit their website at rtix.com.